Sandoz Group AG Brazil
São Paulo, BRSandoz Group AG, headquartered in Basel, Switzerland, is a leading global provider of generic pharmaceuticals and biosimilars. Established in 1886, the company specializes in the development, manufacturing, and marketing of a wide range of medicines across various therapeutic areas, including cardiovascular, oncology, infectious diseases, and immunology. Sandoz offers a comprehensive portfolio of active pharmaceutical ingredients and finished dosage forms, serving patients worldwide. With a strong commitment to quality and affordability, Sandoz plays a pivotal role in enhancing access to essential medicines, positioning itself as a key player in the global healthcare landscape.
Owner profileRichard Saynor↗
Sandoz Group AG France
Paris, FRSandoz Group AG, headquartered in Basel, Switzerland, is a leading global provider of generic pharmaceuticals and biosimilars. Established in 1886, the company specializes in the development, manufacturing, and marketing of a wide range of medicines across various therapeutic areas, including cardiovascular, oncology, infectious diseases, and immunology. Sandoz offers a comprehensive portfolio of active pharmaceutical ingredients and finished dosage forms, serving patients worldwide. With a strong commitment to quality and affordability, Sandoz plays a pivotal role in enhancing access to essential medicines, positioning itself as a key player in the global healthcare landscape.
Owner profileRichard Saynor↗
Sandoz Group AG USA
New York, USSandoz Group AG, headquartered in Basel, Switzerland, is a leading global provider of generic pharmaceuticals and biosimilars. Established in 1886, the company specializes in the development, manufacturing, and marketing of a wide range of medicines across various therapeutic areas, including cardiovascular, oncology, infectious diseases, and immunology. Sandoz offers a comprehensive portfolio of active pharmaceutical ingredients and finished dosage forms, serving patients worldwide. With a strong commitment to quality and affordability, Sandoz plays a pivotal role in enhancing access to essential medicines, positioning itself as a key player in the global healthcare landscape.
Owner profileRichard Saynor↗
Sandoz Group AG Germany
Berlin, DESandoz Group AG, headquartered in Basel, Switzerland, is a leading global provider of generic pharmaceuticals and biosimilars. Established in 1886, the company specializes in the development, manufacturing, and marketing of a wide range of medicines across various therapeutic areas, including cardiovascular, oncology, infectious diseases, and immunology. Sandoz offers a comprehensive portfolio of active pharmaceutical ingredients and finished dosage forms, serving patients worldwide. With a strong commitment to quality and affordability, Sandoz plays a pivotal role in enhancing access to essential medicines, positioning itself as a key player in the global healthcare landscape.
Owner profileRichard Saynor↗
Sandoz Group AG
Basel, CHSandoz Group AG, headquartered in Basel, Switzerland, is a leading global provider of generic pharmaceuticals and biosimilars. Established in 1886, the company specializes in the development, manufacturing, and marketing of a wide range of medicines across various therapeutic areas, including cardiovascular, oncology, infectious diseases, and immunology. Sandoz offers a comprehensive portfolio of active pharmaceutical ingredients and finished dosage forms, serving patients worldwide. With a strong commitment to quality and affordability, Sandoz plays a pivotal role in enhancing access to essential medicines, positioning itself as a key player in the global healthcare landscape.
Owner profileRichard Saynor↗
Takeda Pharmaceutical Company Limited Brazil
São Paulo, BRTakeda Pharmaceutical Company Limited, established in 1781, is Japan's largest pharmaceutical company and a global leader in the biopharmaceutical industry. The company specializes in research and development, manufacturing, sales, and marketing of pharmaceutical drugs, focusing on areas such as oncology, rare genetics and hematology, neuroscience, and gastroenterology. Takeda's global presence spans over 70 countries, with its headquarters in Osaka, Japan. The company's mission is to discover and deliver life-transforming treatments, guided by a commitment to patients, people, and the planet. Under the leadership of Christophe Weber, Takeda has undergone significant globalization and R&D transformation, becoming one of the leading global biopharmaceutical companies.
Owner profileChristophe Weber↗
Takeda Pharmaceutical Company Limited UK
London, GBTakeda Pharmaceutical Company Limited, established in 1781, is Japan's largest pharmaceutical company and a global leader in the biopharmaceutical industry. The company specializes in research and development, manufacturing, sales, and marketing of pharmaceutical drugs, focusing on areas such as oncology, rare genetics and hematology, neuroscience, and gastroenterology. Takeda's global presence spans over 70 countries, with its headquarters in Osaka, Japan. The company's mission is to discover and deliver life-transforming treatments, guided by a commitment to patients, people, and the planet. Under the leadership of Christophe Weber, Takeda has undergone significant globalization and R&D transformation, becoming one of the leading global biopharmaceutical companies.
Owner profileChristophe Weber↗
Takeda Pharmaceutical Company Limited Germany
Berlin, DETakeda Pharmaceutical Company Limited, established in 1781, is Japan's largest pharmaceutical company and a global leader in the biopharmaceutical industry. The company specializes in research and development, manufacturing, sales, and marketing of pharmaceutical drugs, focusing on areas such as oncology, rare genetics and hematology, neuroscience, and gastroenterology. Takeda's global presence spans over 70 countries, with its headquarters in Osaka, Japan. The company's mission is to discover and deliver life-transforming treatments, guided by a commitment to patients, people, and the planet. Under the leadership of Christophe Weber, Takeda has undergone significant globalization and R&D transformation, becoming one of the leading global biopharmaceutical companies.
Owner profileChristophe Weber↗
Takeda Pharmaceutical Company Limited USA
New York, USTakeda Pharmaceutical Company Limited, established in 1781, is Japan's largest pharmaceutical company and a global leader in the biopharmaceutical industry. The company specializes in research and development, manufacturing, sales, and marketing of pharmaceutical drugs, focusing on areas such as oncology, rare genetics and hematology, neuroscience, and gastroenterology. Takeda's global presence spans over 70 countries, with its headquarters in Osaka, Japan. The company's mission is to discover and deliver life-transforming treatments, guided by a commitment to patients, people, and the planet. Under the leadership of Christophe Weber, Takeda has undergone significant globalization and R&D transformation, becoming one of the leading global biopharmaceutical companies.
Owner profileChristophe Weber↗
Takeda Pharmaceutical Company Limited
Osaka, JPTakeda Pharmaceutical Company Limited, established in 1781, is Japan's largest pharmaceutical company and a global leader in the biopharmaceutical industry. The company specializes in research and development, manufacturing, sales, and marketing of pharmaceutical drugs, focusing on areas such as oncology, rare genetics and hematology, neuroscience, and gastroenterology. Takeda's global presence spans over 70 countries, with its headquarters in Osaka, Japan. The company's mission is to discover and deliver life-transforming treatments, guided by a commitment to patients, people, and the planet. Under the leadership of Christophe Weber, Takeda has undergone significant globalization and R&D transformation, becoming one of the leading global biopharmaceutical companies.
Owner profileChristophe Weber↗
Eli Lilly and Company Brazil
São Paulo, BREli Lilly and Company, founded in 1876 by Colonel Eli Lilly, is a global leader in the pharmaceutical industry, headquartered in Indianapolis, Indiana. The company specializes in the discovery, development, and manufacturing of innovative medicines across various therapeutic areas, including diabetes, oncology, immunology, and neuroscience. Lilly's portfolio includes notable products such as Mounjaro (tirzepatide) for type 2 diabetes and Zepbound for obesity, both of which have significantly contributed to the company's growth. In 2025, Eli Lilly became the first pharmaceutical company to achieve a market capitalization exceeding $1 trillion, underscoring its strong market position. The company operates in approximately 125 countries, with offices in 18 countries, reflecting its extensive global presence. Eli Lilly's mission is to make medicines that help people live longer, healthier, and more active lives, emphasizing a commitment to innovation, patient-centricity, and social responsibility. Under the leadership of David A. Ricks, Eli Lilly has achieved record research and development output and innovative medicines, positioning the company for sustained growth.
Owner profileDavid Ricks↗
Eli Lilly and Company United Kingdom
London, GBEli Lilly and Company, founded in 1876 by Colonel Eli Lilly, is a global leader in the pharmaceutical industry, headquartered in Indianapolis, Indiana. The company specializes in the discovery, development, and manufacturing of innovative medicines across various therapeutic areas, including diabetes, oncology, immunology, and neuroscience. Lilly's portfolio includes notable products such as Mounjaro (tirzepatide) for type 2 diabetes and Zepbound for obesity, both of which have significantly contributed to the company's growth. In 2025, Eli Lilly became the first pharmaceutical company to achieve a market capitalization exceeding $1 trillion, underscoring its strong market position. The company operates in approximately 125 countries, with offices in 18 countries, reflecting its extensive global presence. Eli Lilly's mission is to make medicines that help people live longer, healthier, and more active lives, emphasizing a commitment to innovation, patient-centricity, and social responsibility. Under the leadership of David A. Ricks, Eli Lilly has achieved record research and development output and innovative medicines, positioning the company for sustained growth.
Owner profileDavid Ricks↗
Eli Lilly and Company Germany
Berlin, DECompany profile is currently being completed.
Owner profileDavid Ricks↗
Eli Lilly and Company Canada
Toronto, CACompany profile is currently being completed.
Owner profileDavid Ricks↗
Eli Lilly and Company
Indianapolis, USEli Lilly and Company, founded in 1876 by Colonel Eli Lilly, is a global leader in the pharmaceutical industry, headquartered in Indianapolis, Indiana. The company specializes in the discovery, development, and manufacturing of innovative medicines across various therapeutic areas, including diabetes, oncology, immunology, and neuroscience. Lilly's portfolio includes notable products such as Mounjaro (tirzepatide) for type 2 diabetes and Zepbound for obesity, both of which have significantly contributed to the company's growth. In 2025, Eli Lilly became the first pharmaceutical company to achieve a market capitalization exceeding $1 trillion, underscoring its strong market position. The company operates in approximately 125 countries, with offices in 18 countries, reflecting its extensive global presence. Eli Lilly's mission is to make medicines that help people live longer, healthier, and more active lives, emphasizing a commitment to innovation, patient-centricity, and social responsibility. Under the leadership of David A. Ricks, Eli Lilly has achieved record research and development output and innovative medicines, positioning the company for sustained growth.
Owner profileDavid Ricks↗
GSK plc Canada
Toronto, CAGSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK is dedicated to researching, developing, and manufacturing a broad range of innovative medicines and vaccines. The company's portfolio includes specialty medicines in oncology, respiratory, immunology, and inflammation, as well as vaccines for diseases such as shingles, meningitis, and influenza. With a global presence, GSK operates in over 100 markets and employs approximately 66,000 people worldwide. The company's mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. GSK is committed to advancing science and technology to deliver better outcomes for patients and is recognized as one of the world's leading research-based pharmaceutical companies.
Owner profileLuke Miels↗
GSK plc France
Paris, FRGSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK is dedicated to researching, developing, and manufacturing a broad range of innovative medicines and vaccines. The company's portfolio includes specialty medicines in oncology, respiratory, immunology, and inflammation, as well as vaccines for diseases such as shingles, meningitis, and influenza. With a global presence, GSK operates in over 100 markets and employs approximately 66,000 people worldwide. The company's mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. GSK is committed to advancing science and technology to deliver better outcomes for patients and is recognized as one of the world's leading research-based pharmaceutical companies.
Owner profileLuke Miels↗
GSK plc USA
New York, USGSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK is dedicated to researching, developing, and manufacturing a broad range of innovative medicines and vaccines. The company's portfolio includes specialty medicines in oncology, respiratory, immunology, and inflammation, as well as vaccines for diseases such as shingles, meningitis, and influenza. With a global presence, GSK operates in over 100 markets and employs approximately 66,000 people worldwide. The company's mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. GSK is committed to advancing science and technology to deliver better outcomes for patients and is recognized as one of the world's leading research-based pharmaceutical companies.
Owner profileLuke Miels↗
GSK plc Germany
Berlin, DEGSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK is dedicated to researching, developing, and manufacturing a broad range of innovative medicines and vaccines. The company's portfolio includes specialty medicines in oncology, respiratory, immunology, and inflammation, as well as vaccines for diseases such as shingles, meningitis, and influenza. With a global presence, GSK operates in over 100 markets and employs approximately 66,000 people worldwide. The company's mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. GSK is committed to advancing science and technology to deliver better outcomes for patients and is recognized as one of the world's leading research-based pharmaceutical companies.
Owner profileLuke Miels↗
GSK plc
London, GBGSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK is dedicated to researching, developing, and manufacturing a broad range of innovative medicines and vaccines. The company's portfolio includes specialty medicines in oncology, respiratory, immunology, and inflammation, as well as vaccines for diseases such as shingles, meningitis, and influenza. With a global presence, GSK operates in over 100 markets and employs approximately 66,000 people worldwide. The company's mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. GSK is committed to advancing science and technology to deliver better outcomes for patients and is recognized as one of the world's leading research-based pharmaceutical companies.
Owner profileLuke Miels↗
Merck & Co., Inc.
São Paulo, BRMerck & Co., Inc. is a leading global healthcare company dedicated to delivering innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. Established in 1891 as the American affiliate of the Merck Group, it became an independent entity in 1917. The company's portfolio includes treatments for various diseases, vaccines for infectious diseases, and animal health products. With a global presence, Merck operates in over 140 countries, serving millions of patients worldwide. The company's mission is to use the power of leading-edge science to save and improve lives around the world. In 2025, Merck reported revenues of $65.0 billion, with significant contributions from cancer treatments, vaccines, and animal health products. Merck is ranked fifth among the largest biomedical companies by revenue and is committed to advancing healthcare through research and development.
Owner profileRobert Davis↗
Merck & Co., Inc.
Tokyo, JPCompany profile is currently being completed.
Owner profileRobert Davis↗
Merck & Co., Inc.
London, GBCompany profile is currently being completed.
Owner profileRobert Davis↗
Merck & Co., Inc.
Darmstadt, DECompany profile is currently being completed.
Owner profileRobert Davis↗